As part of an added supplement, we at UroToday International Journal present the following added information regarding the article "Androgen Insensitivity Syndrome: Case Report With Review of the Literature." Reponses are provided by corresponding author Dr. Gajanan Bhat.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Q. What does your contribution add to the present knowledge? What's essential to understand about in terms of clinical practice?
A. The most important thing in a clinical practice is the proper clinical examination. In our case, the patient was being treated for primary amenorrhea by various clinicians purely based on some lab reports bypassing the clinical examination. Hence the diagnosis was delayed. Here I would like to emphasize the importance of clinical examination.
Q. Will this replace existing techniques or therapies now or in the near future? Will it impact the standard of care?
A. The case report is not aimed at changing the present standard of care at all. Hence the question doesn't arise.
Q. What are the three things that this technology does or enables that I should know to impact clinical practice? What's your take-home message for me as your colleague?
A. My take-home message is very clear: No investigation can substitute proper clinical examination. Never attempt a shortcut in clinical practice.